rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-6-6
|
pubmed:abstractText |
(11)C-Raclopride has been widely used for PET studies of dopamine D(2/3) receptors in human brain. The long half-life of (18)F may impart advantages to the novel moderate-affinity benzamide (18)F-desmethoxyfallypride and its high-affinity congener (18)F-fallypride for competition studies and for detection of extrastriatal binding. However, the in vivo kinetics of these compounds and the quantification approaches for parametric mapping of their specific bindings have not been systematically compared.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzamides,
http://linkedlifedata.com/resource/pubmed/chemical/Carbon Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/N-((1-allyl-2-pyrrolidinyl)methyl)-5...,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidines,
http://linkedlifedata.com/resource/pubmed/chemical/Raclopride,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D2,
http://linkedlifedata.com/resource/pubmed/chemical/Salicylamides,
http://linkedlifedata.com/resource/pubmed/chemical/desmethoxyfallypride
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0161-5505
|
pubmed:author |
pubmed-author:BartensteinPeterP,
pubmed-author:BuchholzHans-GeorgHG,
pubmed-author:CummingPaulP,
pubmed-author:GründerGerhardG,
pubmed-author:LandvogtChristianC,
pubmed-author:PielMarkusM,
pubmed-author:RöschFrankF,
pubmed-author:SchirrmacherRalfR,
pubmed-author:SchreckenbergerMathiasM,
pubmed-author:SiessmeierThomasT,
pubmed-author:VernalekenIngoI,
pubmed-author:WongDean FDF,
pubmed-author:ZhouYunY
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
964-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15937307-Adult,
pubmed-meshheading:15937307-Benzamides,
pubmed-meshheading:15937307-Brain,
pubmed-meshheading:15937307-Carbon Radioisotopes,
pubmed-meshheading:15937307-Female,
pubmed-meshheading:15937307-Fluorine Radioisotopes,
pubmed-meshheading:15937307-Humans,
pubmed-meshheading:15937307-Ligands,
pubmed-meshheading:15937307-Magnetic Resonance Imaging,
pubmed-meshheading:15937307-Male,
pubmed-meshheading:15937307-Middle Aged,
pubmed-meshheading:15937307-Positron-Emission Tomography,
pubmed-meshheading:15937307-Pyrrolidines,
pubmed-meshheading:15937307-Raclopride,
pubmed-meshheading:15937307-Radiopharmaceuticals,
pubmed-meshheading:15937307-Receptors, Dopamine D2,
pubmed-meshheading:15937307-Salicylamides
|
pubmed:year |
2005
|
pubmed:articleTitle |
Parametric mapping of binding in human brain of D2 receptor ligands of different affinities.
|
pubmed:affiliation |
Department of Nuclear Medicine, University of Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. siessmeier@nuklear.klinik.uni-mainz.de
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|